FDA Puts Science Over Politics In Female Libido Pill Review
The U.S. Food and Drug Administration has made no noteworthy detours in its review of Sprout Pharmaceutical Inc.'s controversial drug flibanserin — the first to treat low sex drive in women...To view the full article, register now.
Already a subscriber? Click here to view full article